Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wu-Chu-Yu Tang Mechanisms in GERD
NCT04118647Phase 4Unknown
- Sponsor
- China Medical University Hospital
- Start
- Oct 2019
- Primary completion
- Sep 2021
- Modality
- HM (Herbal Medicine), TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Wu-Zhu-Yu Decoction in gastroesophageal reflux disease (GERD), sponsored by China Medical University Hospital. Primary endpoints: 24 hours esophageal PH at 28 days and DeMeester score at 28 days. Status: unknown.
02
Drugs
Wu-Zhu-Yu Decoction
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT04118647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04118647.